Blog - Page 425 of 5676 - QualityStocks

FridaySep 20, 2024 3:30 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes and obesity. Recently, the company announced the dosing completion of its human pilot study #2, GLP-1-H24-2, which sought to explore effective oral delivery of GLP-1 drugs. Some evaluated aspects included side effects, blood levels of…

FridaySep 20, 2024 2:30 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Stands Distinct from Industry Players with Buntanetap

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, secured U.S. patent No. 12,042,482 covering methods for treating traumatic brain injury (“TBI”) and nerve injury with buntanetap, the company’s lead drug candidate. “Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43; by inhibiting their translation, the drug improves synaptic transmission, axonal transport, reduces neuroinflammation, and prevents nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule that inhibits multiple neurotoxic proteins simultaneously, making it a promising solution…

FridaySep 20, 2024 12:45 pm

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product

Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium benzoate. According to the announcement, Bitrex is the most bitter substance in the world, and Nutriband will be using it as an aversive agent in its lead product, AVERSA(TM) Fentanyl, an abuse deterrent fentanyl patch. The company’s abuse-deterrent transdermal technology includes the utilization of a proprietary aversive agent coating that uses taste aversion as a means to deter the oral abuse of and accidental exposure to transdermal opioid and stimulant patch products. According…

FridaySep 20, 2024 11:40 am

QualityStocksNewsBreaks – Octane Chooses IBN as Official Media Partner for Upcoming Medical Innovation Forum 2024

Octane, an innovative organization building the SoCal of Tomorrow by connecting people, resources and capital to fuel technology growth in Southern California, has chosen IBN (“InvestorBrandNetwork”), a pioneering corporate communications firm and content distributor, as the official media partner for its next month’s Medical Innovation Forum 2024; the two-day event will be held on Oct. 8–9, 2024, in Irvine. California. The theme of this year’s event is “The Seismic Shift in Healthcare: AI & Innovation.” According to the announcement, IBN will heighten recognition and increase awareness of the Octane event among investors, journalists, consumers and the broader public of the Octane event…

FridaySep 20, 2024 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Joins Chicago Quantum Exchange to Help Advance Quantum Science and Commercialization

The partnership is aimed at furthering quantum education and industry adoption efforts D-Wave will engage with the Chicago Quantum Exchange (“CQE”) community on materials science research, quantum education, and the development of practical optimization use cases across multiple sectors D-Wave’s technology, products and training are expected to play a role in the efforts to support and expand quantum commercialization in the Chicago region D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has joined the Chicago Quantum Exchange (“CQE”), a leading quantum research hub connecting academia, industry…

FridaySep 20, 2024 9:45 am

Domestic Violence Victim Data Breach is a Case Example Showing Critical Need for Monitoring Technology of SuperCom Ltd. (NASDAQ: SPCB)

Police in Australia recently reported a data-sharing error that caused domestic violence victims’ addresses to be published to the offenders accused of harassing them The situation demonstrated the vulnerability of the police service’s public safety measures, leading to recommendation that at least one of the victims move to a new residence, and highlighting the critical need for advanced electronic monitoring (“EM”) technology for domestic violence offenders SuperCom Ltd., a secured tracking solutions provider for governments, is focused on ensuring that its superior PureConnect EM platform is available for tracking the movements of offenders under parole and probation supervision, including accused…

FridaySep 20, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations

Lexaria, a global innovator in drug delivery platforms, announced the appointment of Richard Christopher as its new CEO, replacing Chris Bunka who will serve in his new capacity as Executive Strategic Advisor while remaining Chairman of the Board Lexaria also announced entering a Material Transfer Agreement with an undisclosed pharmaceutical industry partner, leading to speculation of which company has taken this formal step to get closer to Lexaria’s technology The company is focusing on this pharmaceutical industry collaboration and on investigations in cardiometabolic and GLP-1 sectors (alternative diabetes and obesity treatments), a huge sector that particularly needs its unmatched technology…

ThursdaySep 19, 2024 3:21 pm

QualityStocksNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Positioned in Growing Sustainable Energy Market

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is emerging as a particularly promising contender among companies vying for a significant share of the growing sustainable energy market industry, where nickel is a critical component. “Fathom’s strategic focus on Canada’s prolific nickel-copper belts places it in an enviable position. The company’s exploration and development efforts are concentrated in regions renowned for their high-grade mineralization, a factor that significantly enhances its potential for discovering and developing substantial nickel deposits. This geographic advantage, coupled with the company’s technical expertise and financial prudence, sets Fathom Nickel apart from its peers,” a recent article…

ThursdaySep 19, 2024 2:57 pm

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Evolving into Multifaceted Entity with Diversification Strategy

Nightfood Holdings (OTCQB: NGTF) is actively pursuing diversification and expansion into new and emerging sectors. “Nightfood’s journey began with a simple yet compelling premise: address the growing nighttime snacking epidemic. The company’s flagship products – a line of sleep-friendly cookies – are formulated to minimize sleep disruption caused by unhealthy nighttime snacking and nutritionally support sleep quality… Nightfood isn’t content with simply offering snacks. Recent announcements highlight the company’s acquisition of Future Hospitality Ventures, a provider of automation and robotics technology for the hospitality and foodservice industry… This foray into robotics and AI signifies Nightfood’s ambition to become a solutions…

ThursdaySep 19, 2024 11:45 am

Astiva Health Enhances Medicare Open Enrollment with Tailored Care and Comprehensive Benefits

Open enrollment provides people with Medicare an opportunity to review options, make changes to coverage. Evaluating network, extra benefits can help individuals make important plan decisions. Astiva Health provides a wide range of valuable extra benefits, leading the industry with its generous grocery allowance and rebate programs, along with transportation services, fitness programs, vision and hearing care, and more. As Medicare open enrollment approaches, eligible individuals have the chance to review their healthcare options and make important decisions about their coverage. Astiva Health, a leading Medicare Advantage Prescription Drug (“MAPD”) health plan, stands out with its extensive network in Southern…

Site Search

Company Search